National Advertising Division Recommends The Good Feet Store Discontinue Certain Pain Relief Claims for its Arch Support System
New York, NY – August 18, 2025 — As part of its routine marketplace monitoring, BBB National Programs’ National Advertising Division challenged certain express claims and testimonials promoted by The Good Feet Store for its Arch Support System and recommended discontinuing certain unsupported pain relief claims.
Good Feet sells arch supports, including its Arch Support System. At issue for the National Advertising Division (NAD) was the substantiation of certain express claims asserting the product is clinically proven to provide significant pain relief and is engineered to “help you live the life you love without pain,” as well as customer testimonials describing how Good Feet’s arch supports instantly or completely eliminated pain and foot problems.
NAD reviewed the clinical studies provided by Good Feet and found that, due to limitations in certain study parameters, the studies were insufficiently reliable to support the challenged express pain relief claims and testimonials. As a result, NAD recommended that Good Feet discontinue them.
In its advertiser statement, Good Feet said it “will comply with NAD’s recommendations.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for advertising or promotional purposes.
Good Feet sells arch supports, including its Arch Support System. At issue for the National Advertising Division (NAD) was the substantiation of certain express claims asserting the product is clinically proven to provide significant pain relief and is engineered to “help you live the life you love without pain,” as well as customer testimonials describing how Good Feet’s arch supports instantly or completely eliminated pain and foot problems.
NAD reviewed the clinical studies provided by Good Feet and found that, due to limitations in certain study parameters, the studies were insufficiently reliable to support the challenged express pain relief claims and testimonials. As a result, NAD recommended that Good Feet discontinue them.
In its advertiser statement, Good Feet said it “will comply with NAD’s recommendations.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for advertising or promotional purposes.